Viking Therapeutics Future Growth
Future criteria checks 0/6
Viking Therapeutics is forecast to grow earnings and revenue by 4.7% and 70.3% per annum respectively while EPS is expected to grow by 8.6% per annum.
Key information
4.7%
Earnings growth rate
8.6%
EPS growth rate
Biotechs earnings growth | 23.2% |
Revenue growth rate | 70.3% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 28 Apr 2024 |
Recent future growth updates
Recent updates
We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth
Apr 26Viking Therapeutics: Future Weight Loss Heavyweight?
Apr 02We're Hopeful That Viking Therapeutics (NASDAQ:VKTX) Will Use Its Cash Wisely
Jan 09We're Not Very Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Rate
Sep 21Viking Therapeutics (NASDAQ:VKTX) Is In A Good Position To Deliver On Growth Plans
Jun 07We're Not Very Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Rate
Mar 05Viking Therapeutics: Playing Second Fiddle To Madrigal
Aug 30We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth
Jul 13Revisiting Viking Therapeutics
Apr 20We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth
Apr 12We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth
Dec 17Viking Therapeutics: Remaining Bullish And Sticking To My Plan
Aug 27Viking Therapeutics soars 11% on encouraging VK0214 data in rare metabolic disorder
Jun 17Have Insiders Been Selling Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares This Year?
Jan 13Viking Therapeutics announces senior management appointments
Jan 06Do Institutions Own Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares?
Dec 09Viking Therapeutics: Progressing Steadily, But Concerns Remain
Nov 29Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 38 | -193 | -212 | -209 | 9 |
12/31/2025 | N/A | -172 | -166 | -166 | 10 |
12/31/2024 | N/A | -119 | -108 | -106 | 11 |
3/31/2024 | N/A | -94 | -55 | -55 | N/A |
12/31/2023 | N/A | -86 | -73 | -73 | N/A |
9/30/2023 | N/A | -81 | -67 | -67 | N/A |
6/30/2023 | N/A | -74 | -61 | -61 | N/A |
3/31/2023 | N/A | -72 | -63 | -63 | N/A |
12/31/2022 | N/A | -69 | -48 | -48 | N/A |
9/30/2022 | N/A | -62 | -50 | -50 | N/A |
6/30/2022 | N/A | -59 | -47 | -47 | N/A |
3/31/2022 | N/A | -57 | -47 | -47 | N/A |
12/31/2021 | N/A | -55 | -48 | -48 | N/A |
9/30/2021 | N/A | -54 | -41 | -41 | N/A |
6/30/2021 | N/A | -50 | -35 | -35 | N/A |
3/31/2021 | N/A | -44 | -28 | -28 | N/A |
12/31/2020 | N/A | -39 | -22 | -22 | N/A |
9/30/2020 | N/A | -36 | -28 | -28 | N/A |
6/30/2020 | N/A | -32 | -26 | -26 | N/A |
3/31/2020 | N/A | -31 | -26 | -26 | N/A |
12/31/2019 | N/A | -26 | -25 | -25 | N/A |
9/30/2019 | N/A | -24 | -16 | -16 | N/A |
6/30/2019 | N/A | -24 | -18 | -18 | N/A |
3/31/2019 | N/A | -23 | -17 | -17 | N/A |
12/31/2018 | N/A | -22 | -19 | -19 | N/A |
9/30/2018 | N/A | -21 | -20 | -20 | N/A |
6/30/2018 | N/A | -20 | -18 | -18 | N/A |
3/31/2018 | N/A | -19 | -17 | -17 | N/A |
12/31/2017 | N/A | -21 | N/A | -15 | N/A |
9/30/2017 | N/A | -20 | N/A | -13 | N/A |
6/30/2017 | N/A | -18 | N/A | -13 | N/A |
3/31/2017 | N/A | -16 | N/A | -12 | N/A |
12/31/2016 | N/A | -15 | N/A | -11 | N/A |
9/30/2016 | N/A | -16 | N/A | -12 | N/A |
6/30/2016 | N/A | -17 | N/A | -13 | N/A |
3/31/2016 | N/A | -21 | N/A | -11 | N/A |
12/31/2015 | N/A | -23 | N/A | -9 | N/A |
9/30/2015 | N/A | -17 | N/A | -6 | N/A |
6/30/2015 | N/A | -12 | N/A | -3 | N/A |
3/31/2015 | N/A | -27 | N/A | -2 | N/A |
12/31/2014 | N/A | -22 | N/A | -2 | N/A |
9/30/2014 | N/A | -23 | N/A | -1 | N/A |
6/30/2014 | N/A | -23 | N/A | -1 | N/A |
3/31/2014 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VKTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VKTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VKTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VKTX is forecast to have no revenue next year.
High Growth Revenue: VKTX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VKTX's Return on Equity is forecast to be high in 3 years time